Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
9 minute read
  • Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights
December 8, 1:33 PM
  During Thursday's trading, 138 companies set new 52-week lows.

ACHL

Read More
3 minute read
  • Commodities
  • Earnings
  • Eurozone
  • Global
  • Intraday Update
  • Markets
  • News
  • Penny Stocks
  • Small Cap

Nasdaq Gains 100 Points; Rent the Runway Shares Spike Higher

By Lisa Levin
December 8, 1:12 PM
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Thursday.

API

Read More
2 minute read
  • Intraday Update
  • Markets
  • News

Eiger BioPharmaceuticals’ Debt Overview

By Benzinga Insights
December 8, 12:07 PM
Shares of Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR) decreased by 85.08% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.

EIGR

Read More
2 minute read
  • Commodities
  • Earnings
  • Eurozone
  • Global
  • Intraday Update
  • Markets
  • News
  • Penny Stocks
  • Small Cap

Dow Rises 150 Points; US Jobless Claims Increase To 230,000

By Lisa Levin
December 8, 11:03 AM
U.S. stocks traded higher this morning, with the Dow Jones gaining over 150 points on Thursday.

ASC

Read More
1 minute read
  • Biotech
  • General
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Eiger Shares Tumble Despite Phase 3 Study Meets Primary Endpoint

By Vandana Singh
December 8, 10:19 AM
Eiger BioPharmaceuticals Inc (NASDAQ:EIGR) announced topline primary Week 48 data from its Phase 3 D-LIVR study of lonafarnib in two regimens in patients…

EIGR

Read More
2 minute read
  • Earnings

Eiger BioPharmaceuticals’s Return On Capital Employed Overview

By Benzinga Insights
November 24, 10:46 AM
Eiger BioPharmaceuticals (NASDAQ:EIGR) brought in sales totaling $4.02 million during Q3 according to data provided by Benzinga Pro.…

EIGR

Read More
31 minute read
  • Earnings

Earnings Scheduled For November 3, 2022

By Benzinga Insights
November 3, 5:42 AM
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.

AAOI

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Movers
  • News
  • Small Cap
  • Trading Ideas

Eiger BioPharma Shuns Plans For FDA Emergency Use Nod For COVID-19 Treatment

By Vandana Singh
October 5, 9:50 AM
Following FDA feedback, Eiger BioPharmaceuticals Inc (NASDAQ:EIGR) will not submit an emergency use authorization (EUA) application of peginterferon lambda for mild-to-moderate COVID-19.…

EIGR

Read More
1 minute read
  • Analyst Ratings
  • Long Ideas
  • Markets
  • Pre-Market Outlook
  • Price Target
  • Small Cap
  • Trading Ideas

Starbucks To $94? Here Are 5 Other Price Target Changes For Wednesday

By Lisa Levin
September 7, 8:02 AM
Citigroup raised the price target on Starbucks Corporation (NASDAQ: SBUX) from $90 to $94. Citigroup analyst Jon Tower maintained a Neutral rating on the stock. Starbucks shares fell 0.1% to $84.50 in pre-market trading.

COUP

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

BTIG Maintains Buy on Eiger BioPharmaceuticals, Lowers Price Target to $48

By Benzinga Newsdesk
September 7, 7:20 AM
BTIG analyst Robert Hazlett maintains Eiger BioPharmaceuticals (NASDAQ:EIGR) with a Buy and lowers the price target from $57 to $48.

EIGR

Posts pagination

Previous 1 … 5 6 7 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service